A Phase I/II Trial of IO102 and Pembrolizumab With/Without Chemotherapy as First-line Treatment of Metastatic NSCLC
No Thumbnail Available
Identifiers
Date
2019-10-01
Authors
Provencio, M.
Spicer, J.
Garrido, P.
Trigo Perez, J. M.
Viteri, S.
Bosch-Barrera, J.
Insa, A.
Felip, E.
De Castro Carpeno, J.
Coart, E.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
NSCLC, Vaccine, Pembrolizumab